STOCK TITAN

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

Bio-Techne (NASDAQ: TECH) has released its 2024 Corporate Sustainability Report (CSR), highlighting progress in Environmental, Social, and Governance (ESG) initiatives. The report focuses on four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment.

Key developments include:

  • Submitting a commitment to reduce Scope 1, 2, and 3 greenhouse gas emissions
  • Completing the first EcoVadis sustainability assessment, earning a Bronze Medal
  • Continuing to prioritize innovation and community enrichment

CEO Kim Kelderman emphasized the company's dedication to responsible growth and delivering products for advancing therapeutics, vaccines, and diagnostics. The CSR is available on Bio-Techne's website in the Corporate and Social Responsibility section.

Bio-Techne (NASDAQ: TECH) ha pubblicato il suo Report sulla Sostenibilità Aziendale 2024 (CSR), evidenziando i progressi nelle iniziative riguardanti l'Ambiente, il Sociale e la Governance (ESG). Il rapporto si concentra su quattro pilastri chiave: Le Nostre Persone, Avanzare nella Scienza, Governance e Integrità Operativa, e L'Ambiente.

Sviluppi chiave includono:

  • Impegno a ridurre le emissioni di gas serra di Scopo 1, 2 e 3
  • Completamento della prima valutazione di sostenibilità EcoVadis, guadagnando una Medaglia di Bronzo
  • Continuare a dare priorità all'innovazione e al miglioramento della comunità

Il CEO Kim Kelderman ha sottolineato la dedizione dell'azienda alla crescita responsabile e alla fornitura di prodotti per il progresso di terapie, vaccini e diagnosi. Il CSR è disponibile sul sito web di Bio-Techne nella sezione Responsabilità Aziendale e Sociale.

Bio-Techne (NASDAQ: TECH) ha lanzado su Informe de Sostenibilidad Corporativa 2024 (CSR), destacando los avances en las iniciativas de Medio Ambiente, Social y Gobernanza (ESG). El informe se centra en cuatro pilares clave: Nuestro Personal, Avanzando en la Ciencia, Gobernanza e Integridad Operativa, y El Medio Ambiente.

Los desarrollos clave incluyen:

  • Compromiso de reducir las emisiones de gases de efecto invernadero de Alcance 1, 2 y 3
  • Finalización de la primera evaluación de sostenibilidad de EcoVadis, obteniendo una Medalla de Bronce
  • Continuar priorizando la innovación y el enriquecimiento comunitario

El CEO Kim Kelderman enfatizó la dedicación de la empresa al crecimiento responsable y a la entrega de productos para avanzar en terapias, vacunas y diagnósticos. El CSR está disponible en el sitio web de Bio-Techne en la sección de Responsabilidad Corporativa y Social.

Bio-Techne (NASDAQ: TECH)2024년 기업 지속가능성 보고서(CSR)를 발표하며 환경, 사회 및 지배구조(ESG) 이니셔티브에서의 진전을 강조했습니다. 보고서는 네 가지 주요 기둥에 초점을 맞추고 있습니다: 우리의 사람들, 과학의 발전, 지배구조 및 운영의 무결성, 그리고 환경.

주요 발전사항은 다음과 같습니다:

  • 1, 2, 3급 온실가스 배출량을 줄이기 위한 약속 제출
  • 첫 번째 EcoVadis 지속가능성 평가 완료, 브론즈 메달 수상
  • 혁신과 지역 사회 발전에 대한 우선 순위 지속

CEO 킴 켈더맨은 회사의 책임 있는 성장과 치료제, 백신 및 진단을 위한 제품 제공에 대한 헌신을 강조했습니다. CSR은 Bio-Techne 웹사이트의 기업 및 사회적 책임 섹션에서 확인할 수 있습니다.

Bio-Techne (NASDAQ: TECH) a publié son Rapport sur la durabilité d'entreprise 2024 (CSR), mettant en avant les progrès dans les initiatives Environnementales, Sociales et de Gouvernance (ESG). Le rapport se concentre sur quatre piliers clés : Nos personnes, Avancer la science, Gouvernance et intégrité opérationnelle, et L'environnement.

Les développements clés comprennent :

  • Soumission d'un engagement à réduire les émissions de gaz à effet de serre de portée 1, 2 et 3
  • Achèvement de la première évaluation de durabilité EcoVadis, obtenant une médaille de bronze
  • Poursuite de la priorisation de l'innovation et de l'enrichissement de la communauté

Le PDG Kim Kelderman a souligné l'engagement de l'entreprise envers une croissance responsable et la fourniture de produits pour faire avancer les thérapies, les vaccins et les diagnostics. Le CSR est disponible sur le site internet de Bio-Techne dans la section Responsabilité sociale et d'entreprise.

Bio-Techne (NASDAQ: TECH) hat seinen Corporate Sustainability Report 2024 (CSR) veröffentlicht, der die Fortschritte in den Bereichen Umwelt, Soziales und Unternehmensführung (ESG) hervorhebt. Der Bericht konzentriert sich auf vier wesentliche Säulen: Unsere Mitarbeiter, Wissenschaft voranbringen, Unternehmensführung und betriebliche Integrität sowie Die Umwelt.

Wichtige Entwicklungen umfassen:

  • Einreichung eines Engagements zur Reduzierung der Treibhausgasemissionen der Scopes 1, 2 und 3
  • Abschluss der ersten EcoVadis-Nachhaltigkeitsbewertung, Erwerb einer Bronzemedaille
  • Fortsetzung der Priorisierung von Innovation und Gemeinwohl

CEO Kim Kelderman betonte das Engagement des Unternehmens für verantwortungsvolles Wachstum und die Bereitstellung von Produkten zur Förderung von Therapien, Impfstoffen und Diagnostik. Der CSR ist auf der Website von Bio-Techne im Bereich Unternehmens- und soziale Verantwortung verfügbar.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne's EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone of our corporate culture and provide the foundation for our approach to continuously improving our corporate sustainability. The updated CSR is available in the Corporate and Social Responsibility section of Bio-Techne's website.

"I am proud of the progress the team continues to make positioning Bio-Techne for a sustainable future," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "Our global team remains committed to enriching the communities we live and work in, while delivering the innovation the scientific community relies on to catalyze advances in science and medicine. These are achieved while functioning at the highest level of governance and operational integrity. This focus enables the team to grow the organization in a responsible manner and deliver the products necessary to develop and advance the next generation of therapeutics, vaccines and diagnostics that improve global healthcare."

"This latest CSR includes several noteworthy advancements in our sustainability journey," commented Shane Bohnen, Chief Sustainability Officer, General Counsel and Corporate Secretary. "Specifically, we submitted a letter of commitment to reduce our Scope 1, 2 and 3 greenhouse gas emissions, and our reduction targets will be evaluated by the Science Based Targets Initiative (SBTI) in 2026. We also completed our first EcoVadis sustainability assessment to evaluate our performance in environment, labor and human rights, ethics and sustainable procurement, and earned a Bronze Medal in this inaugural evaluation, putting us in the top 67% of all companies assessed. I am looking forward to sharing the team's continued progress furthering our sustainability initiatives."

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations
david.clair@bio-techne.com 
612-656-441

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-issues-2024-corporate-sustainability-report-302249719.html

SOURCE Bio-Techne Corporation

FAQ

What are the key pillars of Bio-Techne's 2024 Corporate Sustainability Report?

Bio-Techne's 2024 CSR focuses on four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment.

Has Bio-Techne (TECH) committed to reducing greenhouse gas emissions?

Yes, Bio-Techne has submitted a letter of commitment to reduce Scope 1, 2, and 3 greenhouse gas emissions, with reduction targets to be evaluated by the Science Based Targets Initiative (SBTI) in 2026.

What was Bio-Techne's performance in the EcoVadis sustainability assessment?

Bio-Techne earned a Bronze Medal in its first EcoVadis sustainability assessment, placing the company in the top 67% of all companies assessed.

Where can investors find Bio-Techne's 2024 Corporate Sustainability Report?

The 2024 Corporate Sustainability Report is available in the Corporate and Social Responsibility section of Bio-Techne's website.

Bio-Techne Corp.

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

10.74B
158.89M
1.04%
99.35%
2.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
MINNEAPOLIS